Press Releases

  • Enesi Pharma Drives Forward Growth Plans with Move to New State-Of-The-Art Headquarters in Oxford

    20th September 2018

    Oxford, UK – 20th September 2018. Enesi Pharma, an innovative pharmaceutical company developing unique injectable solid dose drug-device vaccine products, is delighted to announce the opening of its new headquarters including state-of-the-art research and development facilities in Milton Park, Oxford, in the heart of the UK’s dynamic life science cluster.  Since its launch in 2017… read more

  • Enesi Pharma Welcomes Global Vaccine Expert James Cheyne to its Scientific Advisory Board

    3rd September 2018

    Oxford, UK – 3 September 2018. Enesi Pharma, an innovative pharmaceutical company developing unique injectable solid dose vaccine products, announces the appointment of James Cheyne to its Scientific Advisory Board (SAB). Enesi’s SAB comprises experts in vaccines and preventative health from leading academic, research and international health organisations across the US and Europe. Mr Cheyne… read more

  • Enesi Pharma presenting at the World Vaccine Congress, Washington – Wednesday 4 April 2018

    29th March 2018

    Enesi Pharma are attending the World Vaccine Congress, Washington 3-5 April 2018. David Hipkiss, CEO, will be presenting  our latest developments in the Viral Vectors & Novel Platforms Technology Showcase entitled ImplaVaxTM , Unique needle free solid dose vaccine platform delivering enhanced immunogenicity with ultimate convenience and no cold chain at 10.25am on Wednesday, in Ballroom level… read more

  • Enesi Pharma appoints new international Scientific Advisory Board

    6th November 2017

    Oxford, UK – 6 November 2017. Enesi Pharma, a clinical-stage company developing unique injectable solid dose drug-device combination products, announces the formation of a new International Scientific Advisory Board (SAB). The SAB includes experts in vaccines and preventative health from leading academic/ research and international health organisations in the US and Europe. Commenting on the… read more

  • Enesi Pharma debuts at World Vaccine Congress

    5th October 2017

    Oxford, UK – 10 October 2017. Enesi Pharma, a clinical-stage company developing unique injectable solid dose drug-device combination products, announces its launch as a new company at the World Vaccine Congress, which takes place on 10-12 October in Barcelona, Spain. Enesi is focused on the development of innovative vaccines and therapeutics using its proprietary ImplaVax™… read more